PAN-Biotech GmbH

What PAN-Biotech GmbH does

PAN-Biotech GmbH is a privately held German biotechnology company founded in 1988 and headquartered in Aidenbach, Bavaria. The company manufactures and distributes cell culture media, serum products (including FBS), serum-free media systems, reagents, buffers, water for cell culture, biologics, and cryopreservation media (Cryopan I/II/III). Its products serve research institutions and academia, clinics and healthcare providers, and biopharmaceutical companies engaged in cell and gene therapy, vaccine production, mRNA technology, and antibody manufacturing, with a secondary food technology vertical served through the PAN-Foodtech subsidiary.

The company's core technology platform centers on proprietary serum-free and chemically defined media formulations developed over more than three decades, manufactured at a single integrated facility that includes cGMP-compliant cleanrooms, cold storage, and in-house quality testing laboratories. The technology stack spans RUO to GMP grades, enabling the same supplier relationship to scale from research through clinical and commercial production. Manufacturing capacity ranges from 10L to 1000L batches, available in bottles, canisters, or single-use 2D/3D bag systems, with global cold chain distribution.

PAN-Biotech operates a hybrid product-and-service revenue model combining catalog product sales (one-time purchases via e-commerce and direct enterprise sales) with contract manufacturing/CDMO services (process development, sterile filling, OEM manufacturing) and the Scale-Up Program for biotech startups. Pricing is tiered between university customers (free shipping above €300) and industrial customers (quote-based for large or heavy orders), with standard 30-day payment terms. Distribution is global, centrally controlled from Germany, and supplemented by participation in major industry events including CPHI and Medica.

Name

PAN-Biotech GmbH

Legal name

PAN-Biotech GmbH

Website

https://pan-biotech.de

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

11–50 employees

Short description

PAN-Biotech GmbH is a privately held German manufacturer of cell culture media, sera, reagents, and cryopreservation products serving research institutions, clinics, and biopharmaceutical companies globally, with additional CDMO and Scale-Up Program services for biotech startups.

Ownership category

akta.pro rank

Product category

Cell Culture Media and Bioprocessing Products

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC)

akta.pro secondary industries

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), mRNA/LNP & Nucleic Acid Therapeutics CDMO (HLAGABAF), Gene Therapy Vector Manufacturing & CDMO Services (HLAAACAJ)

Keywords

• Cell culture media
• Biopharmaceutical manufacturing
• Serum products
• Contract manufacturing services
• Cell therapy solutions

Headquarters

HQ city

Aidenbach

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Product Sales: Sale of cell culture products including sera, media, serum-free systems, reagents, buffers, and biologicals to research institutions, clinics, and biopharmaceutical companies worldwide.
2. Contract Manufacturing / CDMO Services: OEM and contract manufacturing services for sterile and non-sterile cell culture products. Services include process development, media fills, bulk production, and sterile filling from 10L to 1000L batches.
3. Scale-Up Program Services: Comprehensive startup support including spin-off assistance, partnering services, and full-service business process outsourcing for biotech companies.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

PAN-Biotech GmbH manufactures and supplies cell culture media, sera, serum-free systems, reagents, buffers, water, biologics, and cryopreservation media for biopharmaceutical, research, and clinical applications. The company also offers CDMO/CMO contract manufacturing services, custom media development, and OEM services from RUO to GMP scale, with production batches ranging from 10L to 1000L. Its product portfolio supports cell and gene therapy, vaccine production, mRNA technology, and antibody production workflows.

Product overview

PAN-Biotech GmbH is a German biotechnology company (since 1988) specializing in cell culture products and services. The product portfolio centers around a comprehensive cell culture ecosystem including: (1) Core Media Products - cell culture media (standard, insect, cell-specific), serum products (FBS, treated sera, human sera), and serum-free alternatives; (2) Reagents & Biologics - reagents (additives, buffers, enzymes, attachment factors, BSA/HSA, antibodies), water for cell culture, and biologics (cytokines, growth factors); (3) Specialty Products - cryopreservation media (Cryopan I/II/III), RNase/DNase neutralizers; (4) Application-Specific Solutions - cell and gene therapy media, vaccine production tools, mRNA technology support, and antibody production systems; (5) GMP-Grade Products - pharmaceutical-quality media and reagents for clinical applications; (6) Contract Manufacturing Services (CDMO/CMO) including single-use bag systems and scale-up support. The company operates as both a product manufacturer and service provider, offering custom media development, OEM manufacturing, and full outsourcing solutions for biotech startups and pharmaceutical companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Cell Culture Media (Medien)

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Cytiva (Danaher): Supplies cell culture media, sera, and bioprocessing solutions for the biopharmaceutical industry. Overlaps with PAN-Biotech's media, serum, and CDMO offering as part of a much broader bioprocessing portfolio.
• Merck KGaA / MilliporeSigma: Life science tools giant offering cell culture media, sera, reagents, and biopharmaceutical CDMO services. Direct competitor in PAN-Biotech's media, reagent, and CDMO categories, with far broader product breadth.
• Corning Life Sciences: Supplies cell culture media, sera, and single-use bioprocessing vessels to biopharmaceutical customers. Overlaps with PAN-Biotech in media, sera, and 2D/3D bag offerings, though within a much broader life sciences portfolio.
• Sartorius AG: Provides bioprocessing equipment, cell culture media, and process solutions for biopharmaceutical manufacturing. Comparable to PAN-Biotech in upstream bioprocessing inputs, though more weighted toward filtration and equipment.
• Thermo Fisher Scientific: Operates Gibco cell culture media and bioservices CDMO businesses, directly competing with PAN-Biotech's media, sera, and CDMO offerings. A broad incumbent that dwarfs PAN-Biotech in scale and global reach.
• Lonza Group AG: Global leader in biologics CDMO and cell & gene therapy manufacturing. Directly comparable to PAN-Biotech's CDMO and cell culture media offerings but at vastly greater scale across mammalian, microbial, and cell therapy modalities.

Direct peers

• Bio-Techne Corporation: Provides reagents, media, cytokines, and growth factors for cell culture and cell therapy applications. Comparable to PAN-Biotech's biologics, reagents, and specialty media offerings, particularly for research and translational-stage customers.
• FUJIFILM Irvine Scientific: Specializes in cell culture media, sera, and CDMO services for cell and gene therapy, vaccines, and biopharmaceutical applications. Closest comparable peer to PAN-Biotech in media specialization and CDMO focus, with overlapping application areas.
• Biosynth (formerly c-LEcta): Swiss-headquartered (with German operations) supplier of enzymes, reagents, and CDMO services for the biopharmaceutical industry. Comparable in size, geographic origin, and product/service mix to PAN-Biotech's CDMO and custom media offerings.
• CellGenix GmbH: German-headquartered supplier of GMP-grade raw materials for cell and gene therapy manufacturing, including media, cytokines, and cryopreservation solutions. Highly comparable niche player focused on the same cell therapy customer base as PAN-Biotech.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@pan-biotechgmbh368
• LinkedInlinkedin.com/company/pan-biotech-gmbh

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PAN-Biotech GmbH